School of Medicine
Showing 421-430 of 469 Results
-
Jacqueline Tsai, MD, FACS
Clinical Associate Professor, Surgery - General Surgery
Current Research and Scholarly InterestsMy research interests are focused on improving breast cancer surgeries. I am interested in novel techniques in surgery to improve cosmetic outcomes, minimize surgical re-excisions and possible augmented reality technologies to enhance surgery.
-
William J. Vasquez McTeigue
Affiliate, Surgery - Vascular Surgery
BioWilliam Vasquez McTeigue is conducting research in the lab of Katherine Hekman, MD, PhD, RPVI, FACS, where he applies induced pluripotent stem cells (iPSCs) to develop regenerative therapies for peripheral artery disease. His work bridges vascular surgery and stem-cell biology, with the goal of advancing treatments for patients with critical limb ischemia and other vascular disorders.
Beyond his current research, William is interested in cardiovascular innovation and translational medicine, aiming to pursue a career at the intersection of surgery, engineering, and regenerative biology. -
Jenny Lymary Veliz-Urzua, DNP, FNP-BC
Affiliate, Surgery - General Surgery
BioJenny L. Veliz-Urzua, DNP, MBA, FNP‑BC, RNFA is a Nurse Practitioner specializing in GI Surgical Oncology at Stanford Health Care. She holds a Doctor of Nursing Practice (DNP) from Purdue Global University, an Executive MBA from the Yale School of Management, Family Nurse Practitioner (FNP) degree from Yale University School of Nursing in 2006, and earned her Bachelor of Science in Nursing from the University of Southern California in 2004.
Her clinical expertise spans hepatobiliary, pancreatic, gastrointestinal, and peritoneal malignancies. She has played a key role in advancing complex regional cancer therapies, working closely with Dr. Byrne Lee, Program Director for Regional Cancer Therapies, to optimize the HIPEC patient-care experience. She has also contributed to the implementation of the Hepatic Arterial Infusion Pump (HAIP) program, supporting its clinical integration and multidisciplinary workflows.
In addition to her GI oncology work, Jenny has served in multiple leadership roles across institutions and cancer services, currently as interim lead for the Breast Surgery and Reconstruction program and Radiation Oncology. In 2020, Jenny was recognized as the American Association of Nurse Practitioners (AANP) California State Award for Nurse Practitioner Advocate recipient, honoring her leadership and contributions to advancing NP practice in the state. -
Banita Verma
Postdoctoral Scholar, General and Vascular Surgery
BioI am Banita Verma, a postdoctoral researcher at Stanford University, currently working with Dr. Fredrick M. Dirbas at the Department of Surgery. Our research focus is to understand the type of cell death and the nature of immune responses triggered by FLASH versus conventional radiotherapy in various murine breast cancer models. Additionally, we aim to explore the role of DAMPs released by dying cells in generating immune responses after both FLASH and conventional radiotherapy. Furthermore, we are interested in studying the mechanism behind the low toxicity of the FLASH compared to conventional radiotherapy to the adjacent non-cancerous tissue. To accomplish this goal, our laboratory is actively collaborating with Dr. Bill Loo, who holds great expertise in the field of radiation oncology.
Before joining Stanford University, I served as a postdoctoral researcher at Karolinska Institutet, Sweden from 2021-2023. My research aimed to study the activation mechanism of Cholineacetyltransferase (ChAT), a pivotal enzyme in acetylcholine synthesis. This enzyme is known to be hypoactive in neurodegenerative conditions such as Alzheimer's and Parkinson's disease. Our group successfully synthesized novel compounds capable of enhancing ChAT activity.
I completed my doctoral research in cancer biology at the Department of Experimental Medicine and Biotechnology, PGIMER Chandigarh, India, in 2021. My work was the evaluation of role of TNF-α mediated Necroptosis in breast cancer cells. My primary research interests are cancer biology and cell death pathways.
